A Guide to Ruxience (Rituximab): How It Works, Dosing, and Side Effects
Ruxience, the brand name for rituximab, is used to treat adults with chronic lymphocytic leukemia (CLL), granulomatosis with polyangiitis (GPA) (Wegener's granulomatosis), microscopic polyangiitis (MPA), rheumatoid arthritis (RA), and certain types of non-Hodgkin’s lymphoma (NHL).
The Role of Injectafer in Managing Iron Deficiency Anemia
Injectafer is a brand name for ferric carboxymaltose, an iron-replacement medication that is given as an intravenous injection to treat iron deficiency anemia (IDA) in adult and pediatric (1 year of age and older) patients. Iron deficiency anemia is a